Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0MK2Y
|
|||
| Former ID |
DIB012942
|
|||
| Drug Name |
Rotavax
|
|||
| Synonyms |
BRV-TV; Rotavirus vaccine (oral, live attenuated); Live attenuated multivalent human-bovine rotavirus vaccine (oral), Aridis; Live attenuated multivalent human-bovine rotavirus vaccine (oral), NIH; Live attenuated multivalent human-bovine vaccine (oral, rotavirus infection), Aridis; Live attenuated multivalent human-bovine vaccine (oral, rotavirus infection), NIH; Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (oral), Shantha Biotechnics; Rotavirus vaccine (oral, live attenuated), PATH/Aridis/Shantha Biotechnics
Click to Show/Hide
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 1/2 | [1] | |
| Company |
Shantha Biotechnics PVT Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00757926) Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.